These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15064911)

  • 1. Effects of dopamine D1- or D2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA.
    Bubar MJ; Pack KM; Frankel PS; Cunningham KA
    Psychopharmacology (Berl); 2004 May; 173(3-4):326-36. PubMed ID: 15064911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors.
    Ball KT; Budreau D; Rebec GV
    Brain Res; 2003 Dec; 994(2):203-15. PubMed ID: 14642646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
    Ramos M; Goñi-Allo B; Aguirre N
    Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats.
    Brennan KA; Carati C; Lea RA; Fitzmaurice PS; Schenk S
    Behav Pharmacol; 2009 Dec; 20(8):688-94. PubMed ID: 19881334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locomotor and discriminative-stimulus effects of cocaine in dopamine D5 receptor knockout mice.
    Elliot EE; Sibley DR; Katz JL
    Psychopharmacology (Berl); 2003 Sep; 169(2):161-8. PubMed ID: 12768268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D
    van de Wetering R; Schenk S
    Psychopharmacology (Berl); 2017 Apr; 234(7):1155-1164. PubMed ID: 28188355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential involvement of dopamine in mediating the discriminative stimulus effects of low and high doses of caffeine in rats.
    Powell KR; Koppelman LF; Holtzman SG
    Behav Pharmacol; 1999 Dec; 10(8):707-16. PubMed ID: 10780285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dopamine D1-like and D2-like antagonists on cocaine discrimination in muscarinic receptor knockout mice.
    Thomsen M; Caine SB
    Eur J Pharmacol; 2016 Apr; 776():71-80. PubMed ID: 26874213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and serotonin antagonists fail to alter the discriminative stimulus properties of ±methylenedioxymethamphetamine.
    Schenk S; Highgate Q
    Behav Pharmacol; 2019 Jun; 30(4):327-334. PubMed ID: 30199389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective dopamine D1- and D2-type receptor antagonists on the development of behavioral sensitization to 7-OH-DPAT.
    Mattingly BA; Himmler C; Bonta T; Rice LL
    Psychopharmacology (Berl); 1998 Dec; 140(4):387-97. PubMed ID: 9888612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generalization of serotonin and dopamine ligands to the discriminative stimulus effects of different doses of ±3,4-methylenedioxymethamphetamine.
    Webster JI; Harper DN; Schenk S
    Behav Pharmacol; 2017 Jun; 28(4):245-254. PubMed ID: 27922542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice.
    Risbrough VB; Masten VL; Caldwell S; Paulus MP; Low MJ; Geyer MA
    Neuropsychopharmacology; 2006 Nov; 31(11):2349-58. PubMed ID: 16855533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats.
    Ramos M; Goñi-Allo B; Aguirre N
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):100-10. PubMed ID: 15338099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic-dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination.
    Goodwin AK; Pynnonen DM; Baker LE
    Pharmacol Biochem Behav; 2003 Mar; 74(4):987-95. PubMed ID: 12667914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization.
    Jeziorski M; White FJ
    Eur J Pharmacol; 1995 Mar; 275(3):235-44. PubMed ID: 7768290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats.
    Liu X; Weiss F
    J Pharmacol Exp Ther; 2002 Mar; 300(3):882-9. PubMed ID: 11861794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex.
    Filip M; Cunningham KA
    J Pharmacol Exp Ther; 2003 Aug; 306(2):734-43. PubMed ID: 12721337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.